Astra Pledges $15 Billion China Investment During Starmer Visit
AstraZeneca Plc will invest $15 billion in China through 2030 to expand medicines and manufacturing and research and development, in a further commitment to the UK drugmaker’s already sizeable presence...
By Deirdre Hipwell · Bloomberg Markets
AstraZeneca Plc will invest $15 billion in China through 2030 to expand medicines and manufacturing and research and development, in a further commitment to the UK drugmaker’s already sizeable presence in the mainland.